Join the club for FREE to access the whole archive and other member benefits.


Company that develops and invests in drugs and technologies which prolong human lifespan.

Rejuveron is an integrated biotechnology platform company that develops and improves therapies and technologies to promote healthy aging and prolong lifespan.

We are a dynamic team of experienced drug discovery and development experts, building a new Incubator lab space at the Bio-Technopark in Schlieren (Zurich).

We provide start-up coaching and funding to entrepreneurial scientists to co-create therapies that benefit our aging population.

Visit website:


Details last updated 18-Dec-2020

Rejuveron Creations

Rejuveron Age Better Live Longer Symposium


Symposium about healthy living organized by Rejuveron (FREE)

People at Rejuveron

Matthias Steger

Biotech Entrepreneur and co-founder and Chief Executive Officer at Endogena Therapeutics

Aksana Labokha

Chief Executive Officer at the Rejuveron

Marc Ramis-Castelltort

Co-Founder and CEO at Senolytic Therapeutics and Rejuveron.

Rejuveron News

Rejuveron raises $20 million for Endogena to advance treatment for eye diseases

CISION PR Newswire - 31-Dec-2021

Funds to develop regenerative therapies for retinitis pigmentosa and advanced age-related macular degeneration


Super summary of 3rd Annual Longevity Therapeutics Summit (LEAF) - 16-Feb-2021

More and more companies making greater and greater progress - 2021 could be an exciting year

Topics mentioned on this page:
Senescent Cells